Trials / Completed
CompletedNCT03107936
Development of a Videogame Prototype Targeting Cigarette and Marijuana Smoking, and Tobacco Product Prevention Among Young Adolescents
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 10 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
To study feasibility and implementation of a education videogame and the effects on adolescents knowledge and beliefs around tobacco products.
Detailed description
The goal for sub-study 4 is to learn more about how an educational videogame can feasibly be implemented and disseminated in youth programs. For this sub-study we will further develop, expand, and refine the smokeSCREEN game and increase the game's reach on a national platform. The study will conduct the proposed evaluation by: working with game developers to develop a web- based version of the game, creating a pre-post survey to measure the effect of the game and building that into the smokeSCREEN game to anonymously collect information on players' knowledge and beliefs around tobacco products, and collaborating with youth programs to pilot test how the game can be implemented in real world settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | smokeSCREEN game | smokeSCREEN is web-based videogame intervention focused on tobacco use prevention in teens. The game has 1.5-2 hours of unique game play and focuses on combustible cigarettes, e-cigarettes, and flavored tobacco products.smokeSCREEN. Guided by the social cognitive theory and the theory of planned behavior, smokeSCREEN addresses a range of challenges that teens often face involving peer pressure and the use of tobacco products. Participants are provided access to the smokeSCREEN game through a private, password-protected website link and instructed to complete the game. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-03-01
- Completion
- 2018-03-01
- First posted
- 2017-04-11
- Last updated
- 2018-10-19
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03107936. Inclusion in this directory is not an endorsement.